Potential Roles of 5-HT3 Receptor Antagonists in Reducing Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Sign Up to like & getrecommendations! Published in 2022 at "Current molecular medicine"
DOI: 10.2174/1566524022666220512122525
Abstract: 5-HT3 receptor antagonists corresponding to ondansetron, granisetron, tropisetron, and palonosetron are clinically accustomed to treat nausea and emesis in chemotherapy patients. However, current and previous studies revealed novel potentials of those ligands in other diseases… read more here.
Keywords: receptor antagonists; roles ht3; ht3 receptor; receptor ... See more keywords